Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of two 20 mg rabeprazole sodium gastro-resistant tablet formulations under fed conditions in healthy Thai subjects
TCTR20221104006Phase 1Unknown
- Sponsor
- Korea United Pharm Inc.
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of rabeprazole (2 arms), sponsored by Korea United Pharm Inc. Status: unknown.
02
Drugs
rabeprazole
Beyond the preview
Go deeper on TCTR20221104006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221104006.